{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:03:06Z","timestamp":1782316986831,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,8]]},"DOI":"10.7759\/cureus.51890","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T01:17:52Z","timestamp":1704763072000},"source":"Crossref","is-referenced-by-count":1,"title":["Long-Lasting SARS-CoV-2 Infection With Post-COVID-19 Chronic Interstitial Pneumonia in a Patient With Chronic Lymphocytic Leukemia Treated Successfully With Intravenous Immunoglobulin"],"prefix":"10.7759","author":[{"given":"Ahmad","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qusai","family":"Al-maharmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad N","family":"Kloub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elrazi A","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2022.11.001","article-title":"Epidemiology and clinical presentation of COVID-19 in older adults","volume":"37","author":"Abul Y","year":"2023","unstructured":"Abul Y, Leeder C, Gravenstein S. Epidemiology and clinical presentation of COVID-19 in older adults. Infect Dis Clin North Am. 2023, 37:1-26. 10.1016\/j.idc.2022.11.001","journal-title":"Infect Dis Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01424-w","article-title":"Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients","volume":"36","author":"Blixt L","year":"2022","unstructured":"Blixt L, Bogdanovic G, Buggert M, et al.. Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients. Leukemia. 2022, 36:476-81. 10.1038\/s41375-021-01424-w","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.04.016","article-title":"Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia","volume":"126","author":"Kainulainen L","year":"2010","unstructured":"Kainulainen L, Vuorinen T, Rantakokko-Jalava K, Osterback R, Ruuskanen O. Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol. 2010, 126:120-6. 10.1016\/j.jaci.2010.04.016","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","unstructured":"WHO Director-General's Remarks at the Media Briefing on 2019-nCoV on 11 February 2020. (2020). Accessed. February 11, 2020: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-remarks-at-the-media-briefing-on-2019-nco...."},{"key":"ref5","unstructured":"WHO COVID-19 Dashboard. (2023). Accessed. December 19, 2023: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00225","article-title":"Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data","volume":"6","author":"Giannakoulis VG","year":"2020","unstructured":"Giannakoulis VG, Papoutsi E, Siempos II. Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data. JCO Glob Oncol. 2020, 6:799-808. 10.1200\/GO.20.00225","journal-title":"JCO Glob Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/M20-5008","article-title":"Transmission of SARS-CoV-2: a review of viral, host, and environmental factors","volume":"174","author":"Meyerowitz EA","year":"2021","unstructured":"Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: a review of viral, host, and environmental factors. Ann Intern Med. 2021, 174:69-79. 10.7326\/M20-5008","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0572","article-title":"Cancer and risk of COVID-19 through a general community survey","volume":"26","author":"Lee KA","year":"2021","unstructured":"Lee KA, Ma W, Sikavi DR, et al.. Cancer and risk of COVID-19 through a general community survey. Oncologist. 2021, 26:e182-5. 10.1634\/theoncologist.2020-0572","journal-title":"Oncologist"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai M","year":"2020","unstructured":"Dai M, Liu D, Liu M, et al.. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020, 10:783-91. 10.1158\/2159-8290.CD-20-0422","journal-title":"Cancer Discov"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05147-z","article-title":"COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group","volume":"102","author":"\u0160imkovi\u010d M","year":"2023","unstructured":"\u0160imkovi\u010d M, Turcs\u00e1nyi P, \u0160pa\u010dek M, et al.. COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group. Ann Hematol. 2023, 102:811-7. 10.1007\/s00277-023-05147-z","journal-title":"Ann Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29438","article-title":"Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: natural history, clinical correlates, and outcomes","volume":"121","author":"Parikh SA","year":"2015","unstructured":"Parikh SA, Leis JF, Chaffee KG, et al.. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: natural history, clinical correlates, and outcomes. Cancer. 2015, 121:2883-91. 10.1002\/cncr.29438","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.071","article-title":"Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis","volume":"9","author":"Morrison VA","year":"2009","unstructured":"Morrison VA. Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis. Clin Lymphoma Myeloma. 2009, 9:365-70. 10.3816\/CLM.2009.n.071","journal-title":"Clin Lymphoma Myeloma"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07715.x","article-title":"Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin","volume":"146","author":"Cooper N","year":"2009","unstructured":"Cooper N, Davies EG, Thrasher AJ. Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin. Br J Haematol. 2009, 146:120-2. 10.1111\/j.1365-2141.2009.07715.x","journal-title":"Br J Haematol"},{"key":"ref15","unstructured":"People Who Are Immunocompromised. (2023). Accessed. June 15, 2023: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-who-are-immunocompromised.html."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2012.11.011","article-title":"Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections","volume":"13","author":"Casulo C","year":"2013","unstructured":"Casulo C, Maragulia J, Zelenetz AD. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections. Clin Lymphoma Myeloma Leuk. 2013, 13:106-11. 10.1016\/j.clml.2012.11.011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S362946","article-title":"Safety and efficacy of antiviral drugs for the treatment of COVID-19: a systematic review","volume":"15","author":"Nie Z","year":"2022","unstructured":"Nie Z, Sun T, Zhao F. Safety and efficacy of antiviral drugs for the treatment of COVID-19: a systematic review. Infect Drug Resist. 2022, 15:4457-66. 10.2147\/IDR.S362946","journal-title":"Infect Drug Resist"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang W","year":"2020","unstructured":"Liang W, Guan W, Chen R, et al.. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020, 21:335-7. 10.1016\/S1470-2045(20)30096-6","journal-title":"Lancet Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2013.809477","article-title":"The clinical significance of hypogammaglobulinaemia and serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukaemia (CLL)","volume":"45","author":"Best OG","year":"2013","unstructured":"Best OG, Crassini K, Freeman JA, Mulligan SP. The clinical significance of hypogammaglobulinaemia and serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukaemia (CLL). Scand J Infect Dis. 2013, 45:729. 10.3109\/00365548.2013.809477","journal-title":"Scand J Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms","volume":"12","author":"Proal AD","year":"2021","unstructured":"Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021, 12:698169. 10.3389\/fmicb.2021.698169","journal-title":"Front Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/219521-long-lasting-sars-cov-2-infection-with-post-covid-19-chronic-interstitial-pneumonia-in-a-patient-with-chronic-lymphocytic-leukemia-treated-successfully-with-intravenous-immunoglobulin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:33Z","timestamp":1707509673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/219521-long-lasting-sars-cov-2-infection-with-post-covid-19-chronic-interstitial-pneumonia-in-a-patient-with-chronic-lymphocytic-leukemia-treated-successfully-with-intravenous-immunoglobulin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.51890","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,8]]}}}